ClosedUnited Kingdom
BH_NonClinical_Pharmacy_Car-T
Bids closed on 8 October 2026. The page stays for reference; similar open tenders are below.
Key facts
- Country
- United Kingdom
- Region
- UKI42
- Estimated value
- not stated
- Procedure
- Direct award
- Published
- Source
- UK Find a Tender
Description
CAR-T therapy (Chimeric Antigen Receptor T-cell therapy) is a new personalised immunotherapy treatment where a patient’s T cells are genetically modified to target cancer cells. The proposed contractor, Bristol Myers Squibb, will supply privately developed CAR T products At the time of writing it is only offered at 8 sites across the UK. The proposed contract is for 5 years with the option to extend by up to a further 5 years. The contract does not commit the Trust to place a minimum or any Order. The price paid to the supplier with be capped at NICE / NHS England approved list prices.
Summary and why it fits you — in your account
Subscribers get a short summary in their language and an explanation of how the tender matches their searches.
Open in your accountOpen on the platform: UK Find a TenderLeaves this site. Terms of participation and documents are there.
Get tenders like this every day
Save a search for the category and new tenders reach your inbox or Telegram before your competitors see them. 5 days free.
No card. Your first saved search is already set up.